personalized medicine

2013, A Year for Point-of-Care Diagnostics Growth

February 4, 2013 Chelli Miller 0

Response Biomedical Corp. (RBM.TO)(RPBIF) is bringing in 2013 with a bang announcing their 2nd US distribution deal since the 1st week in January. Earlier in the month Response Biomedical entered a distribution agreement with US hospital supplier Laboratory Supply Company Inc. (Labsco) to distribute its cardiovascular portfolio of RAMP® products to small hospitals. By the end of January Response Biomedical announced their 2nd US distribution agreement with Fishers Healthcare for their RAMP® Flu A + B tests and RAMP® RSV test on the RAMP® 200.

Cynvenio Biosystems Selected as 2011 FiReStarter Company

May 13, 2011 Herina Ayot 0

Strategic News Service recently announced that Cynvenio Biosystems has been selected as a 2011 FiReStarter company, to be featured at its annual Future in Review technology conference.

2B Blackbio Obtains CE Marking for Identifying Fungal Infections

March 10, 2011 Herina Ayot 0

2B Blackbio, dedicated to developing and marketing new solutions for personalized medicine, has obtained CE Marking for BlackLight Fungal ID Kit, intended for a fast and easy‐to‐use diagnostic test, allowing rapid identification of fungal infections.

Molecular Diagnostics a Natural Fit for Breast Cancer

November 18, 2010 vanderson 0

The growing global incidence of breast cancer has led to an increased demand for molecular diagnostics tests that aid in diagnosing breast cancer.

Luminex Corp. Launches Its First Pharmacogenomics Test for Personalized Medicine

November 17, 2010 vanderson 0

Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.

Genomics Researchers Have a Bone to Pick with Multiple Myeloma

October 13, 2010 vanderson 0

Signal Genetics, a predictive genetic testing company focused on oncology, recently announced that it would work with pharmaceutical company Array BioPharma to advance both companies’ goals of finding biomarkers for myeloma patients.

Bringing a Personal Touch to Treatment Decisions

April 6, 2010 vanderson 1

Having a detailed overview of the patient’s life and health could aid in determining the mechanisms that caused a disease to develop.

Translating Data Into Better Healthcare

March 7, 2010 vanderson 0

Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.

Vivostat’s Technology Turns Blood Into Surgical Glue

February 14, 2010 vanderson 0

Vivostat is a Danish company that uses the patient’s blood to create a personalized surgical glue (fibrin sealant) that can be used for surgical procedures and the treatment of diabetic ulcers.

Positive Peer Review for Aureon’s Prostate Px+

July 7, 2009 vanderson 0

The peer reviewed results published today in the Journal of Urology found that Aureon Laboratories’ Prostate Px+ test is twice as effective as other tools currently available at identifying which patients classified as intermediate-risk have high-risk, life-threatening cancer.

OneMedPlace | Blog

Just another WordPress site